Journal
TRENDS IN MOLECULAR MEDICINE
Volume 26, Issue 11, Pages 1003-1020Publisher
CELL PRESS
DOI: 10.1016/j.molmed.2020.06.005
Keywords
-
Funding
- National Health and Medical Research Council of Australia [1145788, 1101405, 1183070, 1141466]
- Mathison Centenary Fellowship, The University of Melbourne
- Reid Charitable Trusts
- National Health and Medical Research Council (NHMRC) of Australia [1113577]
- NHMRC Medical Research Future Fund Practitioner Fellowship [1154325]
- Australian Government Independent Research Institute Infrastructure Support Scheme [9000220]
- Victorian State Government Operational Infrastructure Support, Australia
- National Health and Medical Research Council of Australia [1101405, 1141466, 1183070] Funding Source: NHMRC
Ask authors/readers for more resources
The accumulation of cellular and environmental microparticles has been linked to many diseases associated with tissue inflammation. These particulate-driven diseases include joint, lung, kidney, cardiovascular, and neurodegenerative disorders. Recently a conserved proinflammatory inflammasome signaling pathway elicited by such microparticles has become apparent. Here, we review disease promoting microparticles and the mechanisms by which they trigger activation of the inflammasome complexes responsible for generating bioactive interleukin1 beta (IL-1 beta) and inducing cell death. We highlight how microparticle-induced inflammasome and cell death responses diverge from canonical inflammasome activators, and discuss the preclinical and clinical targeting of inflammasomes to treat microparticle-driven diseases.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available